Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 869-876

  Yoshizaki, Ayumi ^a   Nakayama, Toshiyuki ^a   Yamazumi, Kazuyuki ^a   Yakata, Yuichi ^a   Taba, Mitsuru ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Colon cancer; IL 11; IL 11 receptor; MAP kinase; PI3 kinase

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CHEMOTAXIS; COLORECTAL TUMOR; CYTOPLASM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METABOLISM; PATHOLOGY; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COLORECTAL NEOPLASMS; CYTOPLASM; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-11; LYMPH NODES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; RECEPTORS, INTERLEUKIN-11; UP-REGULATION;

EID: 37249088620     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.869     Document Type: Article

References (33)

1. Steinberg SM, Barwick KW and Stablein DM: Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group. Cancer 58: 1340-1345, 1986.
2. Ming SC (ed): Pathology of the Gastrointestinal Tract. Williams & Wilkins Press, NJ, pp879-883, 1998.
3. Newland RC, Dent OF, Lyttle MN, Chapuis PH and Bokey EL: Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 73: 2076-2082, 1994.
4. Goseki N, Koike M and Yoshida M: Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 69: 1088-1093, 1992.
5. Du XX and Williams DA: Interleukin-11: review of molecular, cell biology and clinical use. Blood 89: 3897-3908, 1997.
6. Lacroix M, Siwek B, Marie PJ and Body JJ: Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett 127: 29-35, 1998.
7. Hanavadi S, Martin TA, Watkins G, Mansel RE and Jiang WG: Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol, 2006.
8. Deutscher N, Bataille F, Hausmann M, Kiessling S, Muller-Newen G, Leeb SN, Herfarth H, Heinrich PC, Scholmerich J and Rogler G: Functional expression of the interleukin-11 receptor alpha-chain in normal colonic epithelium and colon cancer. Int J Colorectal Dis: 1-9, 2005.
9. Yamazumi K, Nakayama T, Kusaba T, Wen CY, Yoshizaki A, Yakata Y, Nagayasu T and Sekine I: Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J Gastroenterol 12: 317-321, 2006.
10. Paul S, Bennet F, Calvetti J, Kelleher K, Wood C, O'Hara R Jr, Leqary A, Sibley B, Clark S, Williams D and Yang YC: Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87: 7512-7516, 1990. (Pubitemid 20341746)
11. Du XX, Liu Q, Yang Z, Orazi A, Rescoria FJ, Grosfeld JL and Williams DA: Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 272: G545-G552, 1997.
12. Girasole G, Passeri G, Jilka RL and Manolagas SC: Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93: 1516-1524, 1994.
13. Keller DC, Du XX, Srour EF, Hoffman R and Williams DA: Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 82: 1428-1435, 1993.
14. Orazi A, Du X, Yan Z, Kashai M and Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75: 33-42, 1996. (Pubitemid 26250271)
15. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F and Graeve L: Interleukin-6 type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998. (Pubitemid 28448572)
16. Dahmen H, Horsten U, Kuster A, Jacques Y, Minvielle S, Kerr IM, Ciliberto G, Paonessa G, Heinrich PC and Muller-Newen G: Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J 331: 695-702, 1998.
17. Fuhrer DK and Yang YC: Activation of src-family protein tyrosine kinases and phosphatidylinositol-3 kinase in 3T3-L1 mouse preadipocytes by interleukin-11. Exp Hematol 24: 195-203, 1996.
18. Yin T, Yasukawa K, Taga T, Kishimoto T and Yang YC: Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Exp Hematol 22: 467-472, 1994. (Pubitemid 24150367)
19. Comer FI and Parent CA: PI 3-kinases and PTEN: how opposites chemoattract. Cell 109: 541-544, 2002.
20. Gerszten RE, Friedrich EB, Matsui T, Hung RR, Li L, Force T and Rosenzweig A: Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. J Biol Chem 276: 26846-26851, 2001.
21. Tu Y, Gardner A and Lichtenstein A: The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 60: 6763-6770, 2000.
22. Rouse J, Cohen P, Trigon S, Morange M, Alonso LA, Zamanillo D, Hunt T and Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037, 1994. (Pubitemid 24292330)
23. Sturgill TW, Ray LB, Erikson E and Maller JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334: 715-718, 1988.
24. Wu J, Harrison JK, Dent P, Lynch KR, Weber MJ and Sturgill TW: Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol 13: 4539-4548, 1993. (Pubitemid 23220361)
25. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J and Saklatvala J: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27. Cell 78: 1039-1049, 1994. (Pubitemid 24292331)
26. Page DL (ed): Colon and rectum. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th edition. Springer Press, New York, pp113-124, 2002.
27. Sobin LH (ed): Histological typing of intestinal tumors.In: World Health Organization International Histological Classification of Tumors. Springer Press, Berlin, pp8-10, 1989.
28. Dukes CE: The surgical pathology of rectal cancer. J Clin Pathol 2: 95-98, 1949.
29. Knippenberg PH (ed): Isolated Hepatocytes: Preparation, Properties and Applications. Elsevier Press, Amsterdam, pp15-58, 1991.
30. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 9: 525-532, 1988.
31. Chen TR, Hay RJ and Macy ML: Karyotype consistency in human colorectal carcinoma cell lines established in vitro. Cancer Genet Cytogenet 6: 93-117, 1982.
32. Trainer DL, Kline T, McCabe FL, Faucette LF, Field J, Chaikin M, Anzano M, Rieman D, Hoffstein S and Li DJ: Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287-296, 1988.
33. Wu J, Michel H, Rossomando A, Haystead T, Shabanowitz, J, Hunt DF and Sturgill TW: Renaturation and partialpeptide sequencing of mitogen-activated protein kinase (MAP kinase) activator from rabbit skeletal muscle. Biochem J 285: 701-705, 1992.